Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-27

Clinical Trial Update: Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

View source ↗

Summary

A completed clinical trial update evaluating a predictive approach for bleeding risk on anticoagulant therapy in patients with venous thromboembolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Venous Thromboembolism | Status: COMPLETED